Balaxi Pharmaceuticals Reports Continued Solid Growth in Q1 FY23
Hyderabad, Telangana, India Revenue grows 42% in Q1FY23. Pharma Revenue in Latin America up 39%. Profit After Tax up 32% YoY. Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first quarter of financial year
Andhra Pradesh Dominican Republic United States Aashish Maheshwari Balaxi Pharmaceuticals Limited Balaxi Pharmaceuticals Ltd
Source: rashtranews.com